IL6 and cancer: Collectively, our data support the notion that activation of the IL-6/STAT3 and inflammatory-like signaling leads to deleterious effects in normal prostate epithelial cells and tumors, leading to expansion of the cancer stem-like cell compartment and self-renewal properties.